Roche Q3 preview: UBS says 'FX impact turning to a tailwind'
Tweet Send to a Friend
UBS expects limited new strategic news from Roche (OTC: RHHBY) when the Swiss drugmaker reports third-quarter sales on Thursday. In ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




